Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ragnar Källén"'
Autor:
Jana Ekberg, Seema Baid-Agrawal, Bente Jespersen, Ragnar Källén, Ehab Rafael, Karin Skov, Per Lindnér
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 259-269 (2022)
Introduction: Steroid-based immunosuppression after transplantation increases the risk of post-transplant diabetes mellitus (PTDM), with adverse effects on patient and graft survival. In the SAILOR study, we investigated the safety and efficacy of co
Externí odkaz:
https://doaj.org/article/1073c313e6c24da3aabdc331dad89be5
Autor:
Marie Felldin, Rolf Larsson, Bo Nilsson, Ragnar Källén, Olle Korsgren, Gunnar Tufveson, Annika Tibell, Aksel Foss, Sanja Cabric, Javier Sanchez, Torbjörn Lundgren, Kaija Salmela
Publikováno v:
Diabetes. 56:2008-2015
OBJECTIVE—In clinical islet transplantation, the instant blood-mediated inflammatory reaction (IBMIR) is a major factor contributing to the poor initial engraftment of the islets. This reaction is triggered by tissue factor and monocyte chemoattrac
Autor:
Graciela Elgue, Helena Johansson, Lisa Moberg, Kristina Nilsson Ekdahl, Annika Tibell, Torbjörn Lundgren, Aksel Foss, Bo Nilsson, Kaija Salmela, C Berne, Ragnar Källén, Agneta Lukinius, Marie Felldin, Gunnar Tufveson, Olle Korsgren
Publikováno v:
Diabetes. 54:1755-1762
There are strong indications that only a small fraction of grafts successfully engraft in clinical islet transplantation. One explanation may be the instant blood-mediated inflammatory reaction (IBMIR) elicited by tissue factor, which is produced by
Autor:
Gunnar Tufveson, Ragnar Källén, Aksel Foss, C Berne, Torgny Lundgren, Annika Tibell, Bo Nilsson, Marie Felldin, Olle Korsgren, Kaija Salmela
Publikováno v:
Transplantation. 79:1289-1293
Islet transplantation is currently being explored as a treatment for patients with type 1 diabetes. At present, the number of patients becoming insulin-independent is rapidly increasing world-wide applying the transplantation protocol originally desc
Publikováno v:
Scandinavian Journal of Immunology. 58:670-677
Five doses of daclizumab, given initially after kidney transplantation, reduce the rate of acute rejection (AR). Without cyclosporin A (CsA), a protocol, including daclizumab, mycophenolate mofetil (MMF) and corticosteroids (CSs), has recently shown
Autor:
Gunnar Tufveson, Christian Berne, Lisa Moberg, Bo Nilsson, Ragnar Källén, Annika Olsson, Aksel Foss, Marie Felldin, K. Salmela, Annika Tibell, Olle Korsgren
Publikováno v:
Transplantation. 76:1285-1288
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets : Implications for clinical islet transplantation
Autor:
Ø Østraat, Helena Johansson, Aksel Foss, Graciela Elgue, Olle Korsgren, Bo Nilsson, K Nilsson Ekdahl, Annika Tibell, Gunnar Tufveson, Agneta Lukinius, Ragnar Källén, C Berne, Lisa Moberg, Kaija Salmela
Publikováno v:
The Lancet. 360:2039-2045
Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis remains a possible complication. The thrombotic reaction may explain why graft loss oc
Publikováno v:
Nephrology Dialysis Transplantation. 17:1497-1502
BACKGROUND:Considering the fact that donor age is a major risk factor for graft survival, and taking into account the importance attached to the principle of autonomy in the Swedish Health Care Law, we decided that allocation of kidneys from marginal
Autor:
Ragnar Källén, Jana Ekberg, Karin Skov, Lars Mjörnstedt, Bente Jespersen, Michael Olausson, Per Lindnér, Henrik Ekberg
Publikováno v:
Transplantation Research
Ekberg, J, Ekberg, H, Jespersen, B, Källen, R, Skov, K, Olausson, M, Mjörnstedt, L & Lindnér, P 2014, ' An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation ', Transplantation Research, vol. 3, pp. 12 . https://doi.org/10.1186/2047-1440-3-12
Ekberg, J, Ekberg, H, Jespersen, B, Källen, R, Skov, K, Olausson, M, Mjörnstedt, L & Lindnér, P 2014, ' An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation ', Transplantation Research, vol. 3, pp. 12 . https://doi.org/10.1186/2047-1440-3-12
BACKGROUND: Corticosteroids and calcineurin inhibitors (CNIs) are included in renal transplantation immunosuppressive protocols around the world. Well-known side effects are associated with the use of these drugs, including new onset of diabetes afte
Publikováno v:
Transplantation. 65:421-426
The role of oxygen-derived free radicals in pancreatitis after pancreas transplantation was examined in a porcine pancreatic transplantation model. Trypsin activation, protease inhibitor consumption, kininogen consumption, and postoperative graft fun